Sometimes, conference sponsors copyright information so stringently that it is only available on an 'official conference website'. In these cases, the only way you can access this information is to visit the official website while it is still online. (These websites may disappear 6 months or 3 years after a conference has ended. It then takes a good deal of digging to find out where the material is archived, IFit has been archived at all).
The list of conferences below is by no means comprehensive. It represents conferences that we are trying to negotiate the right to permanently archive, index, and cross-reference abstracts. It is a work in progress, so check back regularly to see what progress we are making.
The British HIV Association (BHIVA) has evolved from a fledgling organisation into a 800-member association with a commitment to provide excellence in the care of HIV-infected individuals. Abstracts are available beginning with the 2001 conference.
The European AIDS Clinical Society (EACS) is a not-for-profit group of European physicians, clinicians and researchers in the field of HIV / AIDS. Established in 1991, it now has over 500 members and it aims at bringing together scientists from all over Europe and help at exchanging the latest ination regarding clinical aspects ot the disease.
The Conferences on Retroviruses and Opportunistic Infections are scientifically focused meetings of the world's leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. They are sponsored by the Foundation for Retrovirology and Human Health, in scientific collaboration with the National Institute of Allergy and Infectious Diseases and Centers for Disease Control and Prevention. The mission of the CROI is to provide a forum for basic scientists, clinical investigators, and global health researchers to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and the diseases they produce with the ultimate goal of translating laboratory and clinical research into progress against the AIDS epidemic.
The International AIDS Society (IAS) was founded as a non-profit organisation in connection with the IV International AIDS Conference in Stockholm, 1988, primarily to decide on future venues of the series of International AIDS Conferences and to serve as a network for those working with HIV/AIDS. During the Yokohama Conference in 1994 the IAS was restructured and established a Permanent Secretariat with an appointed Secretary General enabling the IAS to take on responsibility regarding programme and finances of the International AIDS Conferences. Since then IAS has grown and today comprises more than 10,000 members, both individual members (approx. 6,000) and an increasing number of affiliated national AIDS societies. The IAS individual members consisting of mainly scientists and health care professionals, originate from more than 132 countries.
The International AIDS Society (IAS) was founded as a non-profit organisation in connection with the IV International AIDS Conference in Stockholm, 1988, primarily to decide on future venues of the series of International AIDS Conferences and to serve as a network for those working with HIV/AIDS. During the Yokohama Conference in 1994 the IAS was restructured and established a Permanent Secretariat with an appointed Secretary General enabling the IAS to take on responsibility regarding programme and finances of the International AIDS Conferences. Since then IAS has grown and today comprises more than 10,000 members, both individual members (approx. 6,000) and an increasing number of affiliated national AIDS societies. The IAS individual members consisting of mainly scientists and health care professionals, originate from more than 132 countries.
The HIV Drug Resistance Workshops are designed to interest physicians, clinicians, scientists and clinical researchers in the HIV resistance arena. The objectives of the workshops are to:
* Provide an update on resistance to new antiretroviral agents;
* Review mechanisms of HIV drug resistance;
* Present topics specific to HIV pathogenesis, fitness and resistance;
* Expand the scope of the clinical implications of resistance;
* Present new development in epidemiology, and;
* Introduce new resistance technologies and interpretations
The International Workshops on Adverse Drug Reactions and Lipodystrophy in HIV address the range of adverse events, with plenary sessions to review issues such as: HIV and the kidney; cardiovascular risk; and toxicity of new agents. We aim to provide a lively discussion forum for treating physicians and researchers to exchange information, whilst increasing our understanding of lipodystrophy and the many and varied AEs associated with ART. The workshop will also be CME accredited, allowing people to advance their professional development.
The International Workshops on HIV Drug Resistance and Treatment Strategies were merged with the International Workshops on Adverse Drug Reactions and Lipodystrophy in HIV following the 2001 workshop.
For over 20 years, HIV and AIDS have presented historic challenges to our nation's public health, scientific, and medical communities. It is estimated that in the United States, 1.1 million — up from an estimated 850,000 to 950,000 at the end of 2002 — persons are living with HIV. About one-fourth of those with HIV have not yet been diagnosed and are unaware of their infection. The number of people living with AIDS is increasing as effective new drug therapies keep HIV-infected persons healthy longer and dramatically reduce the death rate. Despite extremely beneficial advances in HIV/AIDS treatment in recent years, the epidemic is far from over. An estimated 40,000 Americans become infected with HIV every year, and many of these are young persons under the age of 25. The HIV epidemic is severely impacting communities of color, particularly young people and women. Sixty percent of new infections among men continue to be among men who have sex with men (MSM). Recent evidence suggests there has been a resurgence in unsafe behaviors among some communities of MSM. This conference brings together all of the various players in the HIV prevention arena. It is unique in its sole concentration on the ever important science of HIV prevention.
One of the most informative annual HIV/AIDS meetings in the U.S., the amfAR sponsored National HIV/AIDS Update Conference has attracted health care professionals, service providers, community advocates, and people living with HIV/AIDS. Abstracts are available beginning with the 2001 conference through the final 2005 conference.
Copyright 1980, 2006 - AEGiS.